Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 7 | 2026 | 182 | 2.210 |
Why?
|
| Neuroendocrine Cells | 2 | 2021 | 9 | 1.300 |
Why?
|
| Hyperplasia | 2 | 2021 | 190 | 1.250 |
Why?
|
| Bronchopulmonary Dysplasia | 4 | 2021 | 213 | 0.820 |
Why?
|
| Lung Transplantation | 3 | 2023 | 354 | 0.800 |
Why?
|
| Lung | 13 | 2026 | 1547 | 0.790 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 2106 | 0.730 |
Why?
|
| Waiting Lists | 1 | 2022 | 242 | 0.660 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 253 | 0.600 |
Why?
|
| Tissue Donors | 1 | 2022 | 502 | 0.590 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3814 | 0.570 |
Why?
|
| Cystic Fibrosis | 2 | 2023 | 266 | 0.550 |
Why?
|
| Lung Diseases | 4 | 2023 | 395 | 0.470 |
Why?
|
| Nitroprusside | 1 | 2014 | 35 | 0.430 |
Why?
|
| Infant, Premature | 3 | 2020 | 852 | 0.420 |
Why?
|
| Arterial Pressure | 1 | 2014 | 131 | 0.400 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 379 | 0.400 |
Why?
|
| Infant | 13 | 2026 | 13269 | 0.380 |
Why?
|
| Hypotension | 1 | 2014 | 182 | 0.380 |
Why?
|
| Precision Medicine | 1 | 2016 | 381 | 0.370 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 420 | 0.350 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 | 2021 | 26 | 0.330 |
Why?
|
| Child | 14 | 2026 | 26160 | 0.260 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 449 | 0.230 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8493 | 0.220 |
Why?
|
| Loss of Function Mutation | 1 | 2026 | 170 | 0.220 |
Why?
|
| Child, Preschool | 8 | 2026 | 14984 | 0.210 |
Why?
|
| Cough | 2 | 2022 | 99 | 0.200 |
Why?
|
| Croup | 1 | 2023 | 14 | 0.200 |
Why?
|
| Humans | 25 | 2026 | 130372 | 0.200 |
Why?
|
| Bronchiectasis | 1 | 2023 | 21 | 0.190 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2022 | 4 | 0.180 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2022 | 5 | 0.180 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2022 | 14 | 0.180 |
Why?
|
| Hemoptysis | 1 | 2021 | 22 | 0.170 |
Why?
|
| Protein Precursors | 1 | 2022 | 139 | 0.170 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2021 | 19 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2023 | 153 | 0.170 |
Why?
|
| Retrospective Studies | 9 | 2023 | 17606 | 0.170 |
Why?
|
| Larynx | 1 | 2022 | 72 | 0.170 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 341 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2022 | 168 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 258 | 0.160 |
Why?
|
| Heart Arrest | 1 | 2023 | 373 | 0.150 |
Why?
|
| Education, Medical, Continuing | 1 | 2019 | 130 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2023 | 963 | 0.140 |
Why?
|
| Male | 11 | 2026 | 64517 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2022 | 322 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 177 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2021 | 492 | 0.130 |
Why?
|
| Female | 11 | 2026 | 70274 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 400 | 0.130 |
Why?
|
| Premature Birth | 2 | 2018 | 421 | 0.120 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 504 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 236 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2022 | 1556 | 0.110 |
Why?
|
| Infusions, Subcutaneous | 1 | 2014 | 7 | 0.110 |
Why?
|
| Mutation | 2 | 2021 | 6131 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 552 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 237 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 2297 | 0.100 |
Why?
|
| Adolescent | 4 | 2023 | 20747 | 0.090 |
Why?
|
| Microscopic Polyangiitis | 2 | 2021 | 14 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1617 | 0.080 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 2021 | 39 | 0.080 |
Why?
|
| Genotype | 1 | 2016 | 2605 | 0.080 |
Why?
|
| Pediatrics | 1 | 2019 | 1243 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3393 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3800 | 0.070 |
Why?
|
| Cell Physiological Phenomena | 1 | 2006 | 16 | 0.060 |
Why?
|
| Cells | 1 | 2006 | 20 | 0.060 |
Why?
|
| Tyrosine | 1 | 2006 | 144 | 0.060 |
Why?
|
| Pregnancy | 1 | 2017 | 7381 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 251 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 227 | 0.050 |
Why?
|
| Pedigree | 1 | 2026 | 1683 | 0.050 |
Why?
|
| Bronchoscopy | 1 | 2023 | 177 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2023 | 222 | 0.050 |
Why?
|
| Lung Volume Measurements | 1 | 2022 | 74 | 0.050 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2022 | 38 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2023 | 228 | 0.040 |
Why?
|
| Pulmonary Surfactants | 1 | 2022 | 45 | 0.040 |
Why?
|
| Adult | 1 | 2022 | 31117 | 0.040 |
Why?
|
| Myeloblastin | 1 | 2021 | 18 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 5069 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2021 | 102 | 0.040 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2021 | 20 | 0.040 |
Why?
|
| Alleles | 1 | 2026 | 1685 | 0.040 |
Why?
|
| Peroxidase | 1 | 2021 | 63 | 0.040 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 9 | 0.040 |
Why?
|
| Filamins | 1 | 2021 | 26 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2918 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2023 | 211 | 0.040 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2020 | 40 | 0.040 |
Why?
|
| Respiratory System Abnormalities | 1 | 2021 | 42 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 141 | 0.040 |
Why?
|
| Laryngoscopy | 1 | 2022 | 158 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 253 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2021 | 227 | 0.040 |
Why?
|
| Apoptosis | 1 | 2006 | 1843 | 0.040 |
Why?
|
| Certification | 1 | 2019 | 68 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6421 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2026 | 1605 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2021 | 439 | 0.030 |
Why?
|
| Animals | 4 | 2026 | 33924 | 0.030 |
Why?
|
| Survival Rate | 1 | 2023 | 2131 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1481 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1237 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 806 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2207 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 1927 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 303 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 784 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 2071 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2106 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 3031 | 0.020 |
Why?
|
| Mice | 1 | 2026 | 18213 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6186 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2006 | 23 | 0.020 |
Why?
|
| Amino Acid Transport Systems | 1 | 2006 | 9 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 2006 | 18 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2006 | 16 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Phenylacetates | 1 | 2006 | 27 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2006 | 38 | 0.020 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2006 | 21 | 0.020 |
Why?
|
| Tubulin | 1 | 2006 | 76 | 0.010 |
Why?
|
| Microtubules | 1 | 2006 | 129 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 233 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 837 | 0.010 |
Why?
|
| United States | 1 | 2019 | 11819 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28370 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 3400 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3720 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 2018 | 0.010 |
Why?
|